Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy

This publication has 10 references indexed in Scilit:

• Age-Related Prevalence of Platelet-Associated Immunoglobulins G in Nonthrombocytopenic Patients with Autoimmune Thyroid Disease and Autoimmune Polyglandular Syndrome
  Hormone Research in Paediatrics, 2001
• Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy
  Neurology, 2001
• Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes.
  Diabetes, 2000
• Serum leptin changes in epileptic patients who gain weight after therapy with valproic acid
  Neurology, 1999
• Understanding the underlying metabolic abnormalities of polycystic ovary syndrome and their implications
  American Journal of Obstetrics and Gynecology, 1998
• Expression of Functional GABA_A Receptors in Isolated Human Insulinoma Cells
  Annals of the New York Academy of Sciences, 1998
• Weight gain with valproate or carbamazepine— a reappraisal
  Seizure, 1997
• Carnitine-dependent changes of metabolic fuel consumption during long-term treatment with valproic acid
  The Journal of Pediatrics, 1994
• Valproate and palmitate binding to serum albumin in valproate-treated patients. relation to obesity
  Epilepsy Research, 1993
• In vitro effects of valproate and valproate metabolites on mitochondrial oxidations
  Biochemical Pharmacology, 1992